May 8-10, 2015 - 3rd International Conference on Knowledge Gaps in Parkinson's Disease and other Movement Disorders
To view a PDF of the working program, please click here.
May 8, 2015
| Time | Session | Speaker(s) |
|---|---|---|
| 13:00 | REGISTRATION AND SPONSOR & EXHIBITOR VIEWING | |
| 14:00 | INTRODUCTION | A.J. Espay A. Fasano F. Morgante |
| 14:15 | KEYNOTE SPEAKER LECTURE Alpha-synuclein propagation: from gut and nose to the brain. How are the PD phenotypes determined? |
A. E. Lang |
| KNOWLEDGE GAPS IN THE PATHOGENESIS OF SYNUCLEINOPATHIES Chair: W. Olanow |
||
| 15:00 | From PD to MSA, how aggregation of alpha-synuclein can lead to different neurodegenerative disorders? | W. Meissner |
| 15:30 | Transmission of pathological tau: Do tau strains underlie diverse movement disorders due to tauopathy? | J.Trojanowski |
| 16:00 | CLOSING LECTURE What Prion Diseases can teach us about Parkinson’s disease? |
J. Kordower |
| 16:30 | DISCUSSION | |
| 17:00 | COFFEE BREAK AND SPONSOR & EXHIBITOR VIEWING | |
| KNOWLEDGE GAPS IN DISEASE-MODIFYING TREATMENTS OF PARKINSON'S DISEASE Chair: A. Lozano |
||
| 17:15 | GDNF, BDNF, Neurturin, and others: is there mileage left? | S. Kalia |
| 17:45 | Stem cells: will they ever live up to expectations | W. Olanow |
| 18:15 | CLOSING LECTURE Alpha-synuclein antibodies: is immunotherapy the answer? |
V. Lee |
| 18:45 | DISCUSSION | |
| 19:15 | RECEPTION | |
MAY 9, 2015
| Time | Session | Speaker(s) |
|---|---|---|
| 08:00 REGISTRATION, BREAKFAST AND SPONSOR & EXHIBITOR VIEWING | ||
| KNOWLEDGE GAPS IN NON-MOTOR FEATURES OF PARKINSON'S DISEASE Chair: A. Strafella |
||
| 09:00 | Gut and brain interaction in PD: A low hanging fruit for the treatment of motor fluctuations? | R. Pfeiffer |
| 09:30 | Is dementia inevitable in PD? What might prevent or slows progression of cognitive impairment? | A. Yarnall |
| 10:00 |
CLOSING LECTURE Preventing and treating neuropsychiatric symptoms in PD: What’s the evidence for the role of disease, PD treatments, neurotransmitters, brain regions and pathways? |
D. Weintraub |
| 10:30 | DISCUSSION | |
| 11:00 | COFFEE BREAK AND SPONSOR & EXHIBITOR VIEWING | |
| KNOWLEDGE GAPS IN ADVANCED TREATMENTS OF PARKINSON'S DISEASE Chair: A. Berardelli |
||
| 11:15 | The next frontier in functional neurosurgery: is there promise in adaptive stimulation and focused ultrasound? | N. Lipsman |
| 11:45 | Continuous levodopa infusion, apomorphine infusion, or DBS: how to choose between them? | J. Volkmann |
| 12:15 | CLOSING LECTURE DBS for motor and non-motor disorders: exploring new targets or refining old ones? |
A. Lozano |
| 12:45 | DISCUSSION | |
| 13:15 |
LUNCH, POSTER AND SPONSOR & EXHIBITOR VIEWING SESSION |
|
| KNOWLEDGE GAPS IN TREMOR AND OTHER HYPERKINETIC DISORDERS Chair: R. Chen |
||
| 15:00 | Essential Tremor: what are pathologic studies teaching us? | H. Shill |
| 15:30 | When is tremor not “essential”? The growing spectrum of ET-like disorders | K. P. Bahtia |
| 16:00 | CLOSING LECTURE Is Essential Tremor a syndrome? |
G. Deuschl |
| 16:30 | DISCUSSION | |
| KNOWLEDGE GAPS IN GENETICS OF HYPERKINETIC MOVEMENT DISORDERS Chair: E. Rogaeva |
||
| 17:00 | Dystonia: how are the new gene discoveries advancing our diagnostic and therapeutic missions? | H.A. Jinnah |
| 17:45 | Huntington's Disease: how to translate new molecular insights into treatments? | B. Landwehrmeyer |
| 18:30 | DISCUSSION | |
| 19:00 | END OF DAY 2 | |
MAY 10, 2015
| Time | Session | Speaker(s) |
|---|---|---|
| 08:00 BREAKFAST AND SPONSOR & EXHIBITOR VIEWING | ||
| KNOWLEDGE GAPS IN MOVEMENT DISORDERS NOSOLOGY: SHOULD WE LUMP WE SPLIT? Chair: S. Fox |
||
| 09:00 | Hereditary spastic paraparesis and cerebellar ataxias: how big is the overlap? | A. Durr |
| 09:30 |
Pathogenesis and phenotypes in iron accumulation disorders: Can there be a unified view of NBIA? |
S. Hayflick |
| 10:00 | DYT or that? Where do we PARK them? | N. Mencaccl |
| 10:30 | DISCUSSION | |
| 11:00 | COFFEE BREAK AND SPONSOR & EXHIBITOR VIEWING | |
| KNOWLEDGE GAPS IN FUNCTIONAL (PSYCHOGENIC) MOVEMENT DISORDERS Chair: M. Zurowski |
||
| 11:15 | How can findings on neurobiology of functional (psychogenic) movement disorders translate into treatments? | M.J. Edwards |
| 11:45 | How can psychiatrist contribute to the treatment of functional (psychogenic) movement disorders? | W.C. Lafrance |
| 12:15 | CLOSING LECTURE What have functional (psychogenic) disorders taught us about the physiology of voluntary movements? |
M. Hallet |
| 12:45 | DISCUSSION | |
| 13:15 | FINAL REMARKS Summary of key gaps discussed and next research steps |
A.J. Espay A. Fasano F. Morgante |
| 14:00 | CLOSURE OF THE CONFERENCE | |
